(Q84965538)
Statements
Efficacy and safety of pentavalent human-bovine reassortant rotavirus vaccine when administered with greater than 10 weeks between doses (English)
Michelle G Goveia
Leora Suprun
Robbin F Itzler
Richard McFetridge
Michael J Dallas
Barbara J Kuter